Seite 1 von 4
Neuester Beitrag: 16.09.20 11:59
|Eröffnet am:||18.09.19 09:31||von: maxmansell||Anzahl Beiträge:||83|
|Neuester Beitrag:||16.09.20 11:59||von: maxmansell||Leser gesamt:||16.286|
|Seite: < 1 | 2 | 3 | 4 4 >|
The push for safer skincare products
As the demand for products that lighten and even skin tone continues to influence the beauty industry, both major cosmetics companies and emerging science and technology companies are working to develop healthier solutions for skin lightening products. TFChem, a leader in the field of carbohydrate and fluorine chemistry and subsidiary of Sirona Biochem (TSXV:SBM), has developed a compound called TFC-1067 that is capable of creating an even skin tone without the harmful side effects associated with hydroquinone.
“Most of our projects start with a potential drug or cosmetic agent with limitations that we believe we can improve in terms of both safety and effectiveness. We are constantly searching and exploring new projects,” said Sirona CEO Howard J. Verrico. ”Our scientists recognized that there was a need for better treatment options in skin lightening. Existing products that are effective are associated with toxicity, while existing products that are safe tend to be relatively ineffective. We have applied our platform technology to an existing compound to create a new skin lightener that is both highly effective and safe.”
According to Sirona subsidiary TFChem, TFC-1067 is a synthetically-active part of the arbutins family of compounds, with no possibility of breaking down into hydroquinone. TFC-1067 has been proven in clinical trials to lighten darker areas of the skin with a relatively small dose of the compound. “TFC-1067 (0.2 percent) selectively targets dark spots, highlights the skin’s natural beauty and performs better than hydroquinone (2 percent),” stated TFChem.
Using chemistry techniques originally developed by its subsidiary TFChem, Sirona Biochem is developing safe and effective compounds, including TFC-1067. The company’s proprietary chemistry involves strengthening the bond of a carbohydrate molecule by strategically placing fluorine atoms within the molecule, enabling enhanced stability and bioavailability of carbohydrate-based molecules. Sirona Biochem believes its fluorination platform has the potential to contribute to a number of industries including therapeutics, cosmeceuticals, and biological ingredients.